Analgesics in Japan
In 2021, demand for analgesics increased, as consumers used these products as an effective countermeasure against the side-effects of COVID-19 vaccination, such as high fever and headache, or stocked these products in preparation for home treatment in case of infection due to the shortage of hospital beds. In 2022, analgesics is set to see a rebound from the additional demand in 2021, turning to current value decline. In addition, the demand for analgesics is set to fall as these products are us...
Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in Japan
- Euromonitor International
- October 2022
- List Of Contents And Tables
- ANALGESICS IN JAPAN
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Analgesics faces decline after a strong year, also affected by consumers’ infection prevention practices and slow recovery of inbound travel
- Products that respond to concern about infection with COVID-19 and adverse reactions to vaccination are emerging
- Topical analgesics/anaesthetic continues its recovery due to the appeal of its efficacy on specific areas and formula innovations
- PROSPECTS AND OPPORTUNITIES
- Analgesics set to see recovery, but volume sales expected to remain lower than in 2019
- Steady domestic demand and a resurgence of inbound demand will continue to drive recovery for topical analgesics/anaesthetic
- The proliferation of rival treatments is becoming a threat to analgesics
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN JAPAN
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook